Discontinue use if paradoxical bronchospasm occurs. Not to be used in patients w/ asthma. Not for treatment of acute bronchospasm episodes. COPD deterioration; severe CV disease; urinary retention, narrow-angle glaucoma. Hypokalaemia; transient hyperglycemia. Convulsive disorders or thyrotoxicosis & patients unusually responsive to β2-adrenergic agonists. Monitor plasma glucose in diabetic patients. Not to be taken by patients w/ galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Concomitant use w/ drugs potentially causing hypokalaemia. Severe hepatic impairment. Pregnancy & lactation. Ped <18 yr.
R03AL03 - vilanterol and umeclidinium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
Sign Out
